Latest Debt And Equity News

Thrive Tribe Technologies has raised approximately $250,000 through a discounted share placement and repaid nearly $100,000 in loans by issuing shares, aiming to bolster working capital.

Orezone Gold Corporation reported robust Q2 and H1 2025 results driven by higher gold production and prices, while advancing its Bomboré mine expansion and debuting on the ASX.

Eden Innovations Ltd has announced a non-renounceable entitlement offer to raise approximately $5.7 million, issuing new shares at $0.035 each alongside free options exercisable at $0.07. The capital raise aims to support business expansion and debt reduction.

Insurance Australia Group Limited (IAG) has announced a quarterly dividend of AUD 1.5353 per capital note, with a partly franked distribution reflecting a 6.16% annualised yield, payable mid-September.

Tartana Minerals has secured an additional $0.5 million in non-dilutive financing with plans to refinance into convertible notes, pending shareholder approval at the upcoming AGM.

DigitalX Limited has announced a bold strategy to increase its Bitcoin holdings more than fourfold by the end of 2027, reinforcing its position as a leading Australian digital asset manager.

AVITA Medical reported a 21% revenue increase in Q2 2025 driven by expanded sales and new product launches, yet continues to face net losses and liquidity challenges requiring loan covenant waivers.

Horseshoe Metals has received mining approval for Direct Shipping Ore operations at its Horseshoe Lights project, recommissioned key infrastructure, and secured $851,000 in funding to accelerate near-term copper-gold production.

My Rewards International has made strategic strides by acquiring Fly Wallet, enhancing its Mastercard-backed loyalty offerings, while preparing for ASX reinstatement through a $3.98 million entitlement offer and debt conversion plan.

4DMedical has landed a $10 million strategic investment from Pro Medicus, aimed at accelerating its commercial growth and advancing its CT – VQ™ technology towards FDA clearance in the US.

South Harz Potash Limited has bolstered its balance sheet through a combined A$2.39 million equity raise, positioning itself to pursue a dual-asset strategy targeting new critical minerals while preserving its core German potash project.

Elixinol Wellness reported a 10.8% revenue increase in Q2 2025, supported by improved cash receipts and a focused cost containment program. The company secured new funding and launched a menopause-targeted product, positioning itself for margin growth and profitability in H2.